Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma.
作者信息
Parrondo Ricardo D, LaPlant Betsy R, Elliott Jamie, Fernandez Andre, Flott Caitlin J, Arrington Diedre, Chapin Dustin, Brown Jade, Das Saurav, Roy Vivek, Chanan-Khan Asher A, Ailawadhi Sikander
机构信息
Department of Hematology-Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA.
Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
出版信息
Blood Cancer J. 2024 Sep 5;14(1):152. doi: 10.1038/s41408-024-01134-3.
Abstract
摘要
Zotero 插件